"This is the best use of my time to remain current with what is going on in the industry."
Voluntary Investigator Site Survey survey concluded with 528 responses.
This 13-page position paper on eSource (source data that has been captured by an electronic tool which is a replacement for paper) describes the regulatory environment for the ultimate benefit of all stakeholders involved in EDC.
The eClinical Forum has conducted a global survey of investigational site experiences and expectations with EDC. The survey covers: * Computer use and site facilities. * Current experience with EDC. * Satisfaction with EDC features. * Future expectations.
A survey was undertaken by the eClinical Forum to review the pharmaceutical industry’s experience to date with Electronic Data Capture (EDC) and to better understand future trends. The survey report incorporates the responses of 30 companies, and includes a mixture of EU and US ethical pharmaceutical and biotechnology companies representing 8 of the top 10, 12 of the top 20 and 18 of the top 40 by revenue.
eCF Webinar on RBQM, ATRA, and Fit-for-Purpose Data
Log in to your eCF website account to see more:
RBQM is now a requirement under ICH E6(R3). But how does it fit with other data review activities?
The webinar is available to all our members. Date and Time: Wednesday, 25 February 2026, 14:00 UTC.
eCF Public Webinar March: Turning the ATRA Position Paper into Practice
This webinar focuses on practical implementations of the eCF industry position paper "Strategies for implementing Audit Trail Review"
The webinar is available to all our members as well as the general public. Date and Time: Thursday, 19 March 2026, 9:00 am DST / 1:00 pm UTC. Sign up here
eCF Spring 2026 Workshops Announced!
We are happy to announce our Spring workshops!
Europe/Hybrid: Hosted by Servier outside of Paris on April 14-16 (this will be livestreamed as well)
Americas: Hosted by YPrime outside of Philadelphia, PA on April 28-30
Asia: Hosted by Novartis in Tokyo, Japan on April 2-3